I operate at the intersection of AI, human genetics, and commercial strategy. At Genomics, I help pharmaceutical and biotech organizations bring large-scale human genetics into earlier, more confident R&D decision-making—through a combination of advanced analytics, AI-enabled tooling, and strategic consulting support.

My work centers on partnering with senior R&D, statistical genetics, and strategy leaders to operationalize genetics across the pipeline: accelerating target discovery, strengthening validation, improving translational confidence, and identifying patient populations more likely to respond to therapy.

Over the past 20 years, I’ve:

•	Built, led, and mentored high-performing sales teams in AI and SaaS.
•	Managed global accounts and developed go-to-market strategies that drive adoption.
•	Closed multi-million-dollar enterprise engagements and partnerships across R&D industries 
•	Negotiated strategic agreements that expand revenue and accelerate growth.

I’m also the author of Mastering AI Sales: Essential Knowledge for B2B Professionals, a practical playbook that equips founders, consultants, and sales leaders with frameworks to win complex AI sales.
👆 Now available – click the link in my profile header to get your copy.

Specialties

•	AI-Enabled Human Genetics / Genomics Commercial Strategy
•	Building & Scaling Sales Teams
•	Enterprise AI Sales & Stakeholder Management
•	Go-to-Market Strategy (Consulting + Product Hybrid Models)
•	Strategic Partnerships & Revenue Expansion
•	Cross-Functional Leadership & Commercial Alignment

Let’s connect if you’re scaling AI solutions, leading enterprise transformations, or looking to accelerate sales impact in complex markets.

David Walker

Early JPM takeaways…

• Causal genetics is firmly front and center, increasingly used to de-risk target identification and validate programs earlier in development.
• Patient stratification is no longer optional. Leaders are entering the clinic with greater emphasis on clear responder hypotheses and stronger supporting evidence.
• AI is maturing quickly. Fewer proof-of-concept discussions, more concrete examples of measurable impact across R&D.
• Funding sentiment appears cautiously improved, particularly for companies with differentiated science and disciplined, evidence-led strategies.

The Genomics leadership team is here all week and we’d be happy to connect and compare notes.

#jpm2026 #Genomics

VP of Client Service | Leading Enterprise AI Partnerships | Team Builder | Author of Mastering AI Sales | MBA, MSc.

JPM was an outstanding experience. The energy, quality of conversations, and level of innovation throughout the week were exceptional.

We were delighted to host a Genomics reception, where we shared how Mystra, our AI enabled platform, enables teams to apply human genetics more effectively to R&D decision-making. The depth of engagement reinforced just how central genetics has become to smarter target selection and clinical decisions.

A few key takeaways stood out for me…

1. Platforms must change decisions
AI creates value only when it changes decisions e.g. which targets advance, which programs stop earlier, and which patients enter trials. The strongest platforms enable fewer, higher-confidence bets.

2. Data advantage ≠ more data
The ultimate advantage is signal, not scale. Rare disease cohorts, longitudinal datasets, and multi-omics data with clinical context enable better questions to be asked and reduce false confidence.

3. Causal genetics is becoming foundational
Human genetics is increasingly being used to improve probability of success, de-risk programs earlier, enable patient stratification, and support smarter trial design.

The next phase of R&D won’t be defined by who moves fastest, but by who makes the best decisions earliest, using well-curated data, causal evidence, and AI together.

#JPM26 #Genetics #TargetValidation #PatientStratification #DrugDevelopment

I am looking forward to participating in the 25th Precision Medicine World Conference (PMWC 2026), taking place March 4–6, at the Santa Clara Convention Center in California, co-hosted by Stanford, UCSF & Yale.

Meet me at #PMWC26, March 4-6, where over 400 speakers, including Nobel Laureates Mary Brunkow and W.E. Moerner, OpenAI's President & Co-Founder, FDA Commissioner (Fmr), Judy Faulkner (Epic), Carl June (UPenn), David Sinclair (Harvard) & more will gather to help advance precision medicine & AI.

Speakers: www.PMWCintl.com/Speakers
Program: www.PMWCintl.com/Program

Register for PMWC 2026 to save using my personal code: https://lnkd.in/e9MQeSUr

 PMWC - Precision Medicine World Conference
#PMWC26 #PMWC2026 #PrecisionMedicine #Biotech

Open article: PMWC 2026 Registration, Tickets & Pricing by pmwcintl.com

PMWC 2026 Registration, Tickets & Pricing

Great to see the Genomics team out in force at #FOG2026 
If you’re at FOG, make sure you stop by by Booth #77 to say hello and check out the Mystra D&D Quest, a fun, hands-on way to experience how we support drug target discovery and development through human genetics and multi-omics.   Plus Dirk Paul, Head of Development, talking about: “The Genome and Beyond: Advancing Drug Discovery and Development” Today 12:00–12:30 | Multi-Omics Stage
Have a great show, team 👋
#DrugDiscovery #MultiOmics #Genomics #DrugDevelopment #FOG2026 #FrontLineGenomics

Day 1 at #FOG2026 is here 🚀 

You can find us at Booth #77 - come say hello to the team and try our iconic Mystra D&D Quest 🧙 - an interactive challenge that gives you a hands-on experience with our drug target discovery and development platform! 

🎤 Today | 12:00 - 12:30 | Multi-Omics stage
Join Dirk Paul, Head of Development, for "The Genome and Beyond: Advancing Drug Discovery and Development"
What to expect:
💡 Insights into Genomics' genotype-phenotype platform & analytical pipelines
🧬  A deep dive into how multi-omics integration drives target identification & data-driven patient stratification
🌍  Real-world case case studies showcasing risk prediction and pharmacomimetic approaches in action

See you on the floor 👋 

#drugdiscovery #MultiOmics #Genomics #DrugDevelopment Front Line Genomics

Quantori

Empower deep domain expertise and thrilling technology expertise with technology solutions by key technology vendors on the market

Head Technology Solutions & Partnership

Grid Dynamics

Experienced engineering executive with years of hands-on in-field expertise in developing world-class enterprise solutions, serving as an R&D and innovation leader. 

Known for clear communication, decisive problem-solving, and effective decision-making.

Solutions Architect and advocate for software development, dedicated to team growth, leadership development, and the creation of mission-critical and innovative products.

Specializes in Generative AI, cloud solutions, digital transformation, IoT, AI/ML, and the development of large-scale and distributed systems.

Brings prior experience in industrial automation, machine learning, artificial intelligence, eCommerce solutions, analytical platforms, wearable technology, and high-availability embedded systems.

Passionate about next-generation city ecosystems, autonomous vehicles, and self-managed infrastructure solutions

VP of Engineering

EPAM Systems

Director of Engineering; Deputy CTO

Director of Engineering; Sr Director of Engineering; Global Delivery Director

Atea A/S

Engineering Manager

GlobalLogic

DELFI Software

Founder

INEC

Design and development of automation motion control systems for industrial and production enterprises

Intern; Software Engineer; 

As the VP of Engineering at Grid Dynamics, I lead engineering teams that deliver innovative and mission-critical solutions for our clients across various industries and domains. I have over 15 years of experience as a software engineer, software executive, and solutions architect, specializing in cloud computing, digital transformation, discovery solutions, IoT, AI/ML, and large-scale and distributed systems.

I am passionate about creating and growing high-performance engineering teams, developing and mentoring leaders, and building cutting-edge products that solve real-world problems. I have successfully led and executed multiple challenging and complex projects, ranging from industrial automation and eCommerce platforms to wearable devices and self-driven cars. I am always eager to learn and apply new technologies to create value and impact for our customers and partners.

taplio

The Battle

David Walker

Konstantin Malyshev

Followers

Posts

Engagements

Likes

Performance ScoreDavid Walker's LinkedIn Performance

Ready to grow your LinkedIn presence?

taplio

The Battle

David Walker

Konstantin Malyshev

Followers

Posts

Engagements

Likes

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}David Walker's LinkedIn Performance

Ready to grow your LinkedIn presence?

Performance ScoreDavid Walker's LinkedIn Performance